Reuters: Regulatory News: Rockwell Medical's iron deficiency drug succeeds in trial

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Rockwell Medical's iron deficiency drug succeeds in trial Jul 11th 2013, 10:39 July 11 | Thu Jul 11, 2013 6:39am EDT July 11 (Reuters) - Rockwell Medical Inc said a late-stage trial of its experimental iron deficiency drug met the main goal of improving patients' hemoglobin levels. The study was the first of two planned late-stage trials, and tested the drug, SFP, in adult patients with chronic kidney disease.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions